The data, published only on ClinicalTrials.gov, showed that elderly participants who received the mRNA flu shot faced a greater risk of serious adverse events, including kidney failure and acute respiratory failure.<\/strong><\/em><\/p>\n https:\/\/childrenshealthdefense.org\/defender\/pfizer-omitted-trial-data-showing-higher-mortality-kidney-failure-seniors-mrna-flu-shot\/?<\/a><\/p>\n https:\/\/clinicaltrials.gov\/study\/NCT05540522<\/a><\/p>\n “The trial showed zero benefit…”<\/p>\n https:\/\/www.zerohedge.com\/medical\/pfizer-mrna-influenza-vaccine-failed-clinical-trial-among-seniors-fda-commissioner<\/a><\/p>\n <\/p>\n","protected":false},"excerpt":{"rendered":" UPDATED The trial data published in the NEJM last week focused exclusively on adults 18 to 64, even though nearly 60% of the Phase 3 clinical trial participants were 65 or older \u2014 suggesting Pfizer intends to heavily market its … Continue reading AND<\/h3>\n
A Study to Evaluate a Modified RNA Vaccine Against Influenza in Adults 18 Years of Age or Older<\/h4>\n
AND<\/h3>\n
Pfizer mRNA Influenza Vaccine ‘Failed’ In Clinical Trial Among Seniors: FDA Commissioner<\/h4>\n